Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment

Title: Thermo Fisher Expands Bioprocessing Capabilities with $4 Billion Acquisition of Solventum’s Purification and Filtration Division

In a strategic move to enhance its bioprocessing capabilities, Thermo Fisher Scientific has announced the acquisition of the Purification and Filtration business segment from Solventum, a spinoff of 3M. The deal, valued at $4 billion, positions Thermo Fisher to significantly expand its offerings in the biopharmaceutical manufacturing sector.

The acquired business is renowned for its high-quality filters and membranes that are critical in various global applications within the biopharmaceutical industry. This acquisition not only broadens Thermo Fisher’s portfolio but also strengthens its position as a leader in serving science and technology markets.

For more details on this significant expansion by Thermo Fisher, visit MedCity News at [Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment](https://medcitynews.com/2025/02/thermo-fisher-acquisition-solventum-bioproessing-filters-purification-tmo-solv/).

Published on February 25, 2025, by MedCity News.

Newsflash | Powered by GeneOnline AI

Source: https://medcitynews.com/2025/02/thermo-fisher-acquisition-solventum-bioproessing-filters-purification-tmo-solv/